Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-21

Clinical Trial Update: Simvastatin as a Treatment for Pulmonary Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update investigating simvastatin for pulmonary hypertension across Phase 1 and Phase 2, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Imperial College London | Conditions: Pulmonary Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-21